title: Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer.
authors.forename: Jon K
authors.initials: JK
authors.lastname: Bjerregaard
authors.forename: Barbara M
authors.initials: BM
authors.lastname: Fischer
authors.forename: Mie H
authors.initials: MH
authors.lastname: Vilstrup
authors.forename: Henrik
authors.initials: H
authors.lastname: Petersen
authors.forename: Michael B
authors.initials: MB
authors.lastname: Mortensen
authors.forename: Christian R
authors.initials: CR
authors.lastname: Hansen
authors.forename: Jon T
authors.initials: JT
authors.lastname: Asmussen
authors.forename: Per
authors.initials: P
authors.lastname: Pfeiffer
authors.forename: Poul F
authors.initials: PF
authors.lastname: Høilund-Carlsen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy*; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D005641:Tegafur / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014498:Uracil / Q000627:therapeutic use
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005641:Tegafur; D014498:Uracil; D002955:Leucovorin